RosenbloomJ. An appreciation of Henry Bence Jones, MD, FRS (1813–1873). Ann Med Hist1919;2: 262–4.
2.
ColeyNG. Henry Bence Jones MD, FRS (1813–1873). Notes Rec R Soc Lond1973;28: 31–56.
3.
RosenfeldL. Henry Bence Jones (1813–1873): The best “chemical doctor” in London. Clin Chem1987;33: 1687–92.
4.
PutnamFW. Henry Bence Jones: The best chemical doctor in London. Perspect Biol Med1993;36: 565–79.
5.
JonesH Bence. On the presence of sulphur in cystic oxide, and an account of a cystic oxide calculus. Med Chir Soc Trans1840;23: 192–8.
6.
JonesH Bence. On Gravel, Calculus, and Gout: Chiefly an Application of Professor Liebig's Physiology to the Prevention and Cure of these Diseases. London: Taylor and Walton, 1842.
7.
JonesH Bence. On intermitting diabetes, and on the diabetes of old age. Med Chir Trans1853;36: 403–32.
8.
JonesH BenceDupréA. On a fluorescent substance, resembling quinine, in animals; and on the rate of passage of quinine into the vascular and non-vascular textures of the body. Proc R Soc London1866, 15: 72–93.
9.
Obituary. Henry Bence Jones, MD, MA, FRCP, FRS. Med Times Gaz1873;1: 505–8.
10.
AllbuttC. Dr. Bence Jones. In: CoopeR, ed. The Quiet Art, A Doctor's Anthology. Edinburgh: E&S Livingstone Ltd, 1958: 74–5.
11.
DarwinF. The Life and Letters of Charles Darwin Including an Autobiographical Chapter, vol. 3. London: John Murray, 1887: 31.
12.
HuxleyL. Life and Letters of Thomas Henry Huxley, vol. 1. New York: Appleton, 1902: 242.
13.
JonesH Bence. The Life and Letters of Faraday, vols 1 and 2 (2nd edn). London: Longmans, Green and Co., 1870.
14.
TweneyRD. Books and the heroic science of Michael Faraday. AB Bookman, 21 October 1991: 1557–60.
15.
CopeZ. Florence Nightingale and the Doctors. London: Museum Press Ltd, 1958: 21–3.
16.
JonesH Bence. The Royal Institution: Its Founders and its First Professors. London: Longmans, Green and Co., 1871 (reprinted New York: Arno Press, 1975).
17.
Obituary. Dr. Henry Bence Jones. Lancet, 26 April 1873: 614–15.
18.
SollyS. Remarks on the pathology of mollifies ossium, with cases. Med Chir Trans1844;27: 435–61.
19.
KyleRA. History of multiple myeloma. In: WiernikPHCancellosGPDutcherJPKyleRA, eds. Neoplastic Diseases of the Blood (3rd edn). New York: Churchill Livingstone, 1996: 411–22.
20.
ClampJR. Some aspects of the first recorded case of multiple myeloma. Lancet1967;ii: 1354–6.
21.
SnapperIKahnA. Historical background. In: SnapperIKahnA, eds. Myelomatosis. Fundamentals and Clinical Features. Baltimore: University Park Press, 1971: 1–9.
22.
MacIntyreW. Case of mollities and fragilitas ossium, accompanied with urine strongly charged with animal matter. Med Chir Soc1850;33: 211–32.
23.
JonesH Bence. Papers on chemical pathology; prefaced by the Gulstonian Lectures, read at the Royal College of Physicians, 1846. Lancet1847; ii: 88–92.
24.
JonesH Bence. On the new substance occurring in the urine of a patient with mollities ossium. Philos Trans R Soc Lond Biol1848;138: 55–62.
25.
DalrympleJ. On the microscopical character of mollities ossium. Dublin J Med Sci1846;2: 85–95.
26.
RobertsW. A Practical Treatise on Urinary and Renal Diseases, Including Urinary Deposits. Philadelphia: Lea Brothers, 1885: 186.
27.
von RustizkyJ. Multiples myelom. Dtsch Z Chir1873;3: 162–72.
28.
KahlerO. Zur Symptomatologie des multiplen Myeloms; Beobachtung von Albumosurie. Prag Med Wochenschr1889;14: 45–9.
29.
WrightJH. A case of multiple myeloma. Johns Hopkins Hosp Rep1900;9: 359–66.
30.
OslerW. The Principles and Practice of Medicine. New York: D Appleton & Co., 1892: 728.
31.
OslerW. The Principles and Practice of Medicine (7th edn). New York: D Appleton & Co., 1909: 674–5.
32.
EdelmanGM. The structure and function of antibodies. Sci Am1970;223: 34–42.
33.
GeschickterCFCopelandMM. Multiple myeloma. In: Tumors of Bone. New York: American Journal of Cancer, 1931: 430–75.
34.
PutnamFWHardyS. Proteins in multiple myeloma. III. Origin of Bence Jones protein. J Biol Chem1955;212: 361–9.
35.
KorngoldLLipariR. Multiple-myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gamma-globulin and multiple-myeloma serum proteins. Cancer1956;9: 262–72.
36.
PorterRR. Structural studies of immunoglobulins. Science1973;180: 713–16.
37.
EdelmanGM. Antibody structure and molecular immunology. Science1973; 180: 830–9.
38.
EdelmanGMGailyJA. The nature of Bence Jones proteins. Chemical similarities to polypeptide chains of myeloma globulins and normal ?-globulins. J Exp Med1962;116: 207–27.
39.
HilschmannNCraigLC. Amino acid sequence studies with Bence Jones proteins. Proc Natl Acad Sci USA1965;53: 1403–9.
40.
PutmanFWTitaniKWiklerMShinodaT. Structure and evolution of kappa and lambda light chains. Cold Spring Harb Symp Quant Biol1967;32: 9–30.
41.
PutnamFW. From animal matter to antibody — A trail of research in cancer. Perspect Biol Med1972;15: 356–79.
42.
PutnamFW, ed. Immunoglobulins I. Structure. The Plasma Proteins, vol. 3 (2nd edn). New York: Academic Press, 1977: 1–12.
43.
OssermanEFTakatsukiKTalalN. The pathogenesis of “amyloidosis”: Studies on the role of abnormal gamma globulins and gamma globulin fragments of the Bence Jones (1-polypeptide) type in the pathogenesis of “primary” and “secondary amyloidosis”, and the “amyloidosis” associated with plasma cell myeloma. Semin Hematol1964;1: 3–85.
44.
KyleRABayrdED. “Primary” systemic amyloidosis and myeloma. Discussion of relationship and review of 81 cases. Arch Intern Med1961;107: 344–53.
45.
GlennerGGTerryWHaradaMIserskyCPageD. Amyloid fibril proteins. Proof of homology with immunoglobulin light chains by sequence analyses. Science1971;172: 1150–1.
46.
GlennerGGEinDEanesEDBladenHATerryWPageDL. Creation of ‘amyloid’ fibrils from Bence Jones proteins in vitro. Science1971;174: 712–14.
47.
StoneMJFrenkelEP. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis. Am J Med1975;58: 601–19.
48.
SolomonA. Bence Jones proteins and light chains of immunoglobulins. N Engl J Med1976; 294: 17–23, 91–8.
49.
StoneMJ. Amyloidosis: A final common pathway for protein deposition in tissues. Blood1990;75: 531–45.
50.
BuxbaumJNChubaJVHellmanGCSolomanAGalloGR. Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med1990;112: 455–64.
51.
SolomonAWeissDTKatrineAA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med1991;324: 1845–51.
52.
LongoDL. Plasma cell disorders. In: IsselbacherKJBraunwaldEWilsonJDMartinJBFauciASKasperDL, eds. Harrison's Principles of Internal Medicine (13th edn). New York: McGraw-Hill, 1994: 1618–25.
53.
KyleRA. Plasma cell disorders. In: BennettJCPlumF, eds. Cecil Textbook of Medicine (20th edn). Philadelphia: WB Saunders, 1996: 958–68.